Management

Accentus Medical’s management team has a wealth of experience in the development, commercialisation and regulatory requirements of advanced surface technologies and treatments for medical devices.

Philip AggChief Executive Officer Martin PickfordSenior Vice President,
Global Business Development
James ShawcrossVice President,
Quality and Research & Development
Andrew TurnerChief Scientific Officer Thomas SalomonExport Sales Manager Adrian GodwinProduction Manager David LewisLaboratory Manager

Philip Agg

Chief Executive Officer

As Chief Executive Officer, Philip is focused on further expanding Accentus Medical’s business through the development, production, licensing and exploitation of new technologies and specialist coatings to the orthopaedic and medical device manufacturing industry.

Prior to becoming Accentus Medical’s Chief Executive Officer, Philip was appointed Managing Director of Accentus plc in August 2003. At this time Accentus plc was a wholly owned subsidiary of AEA Technology plc (AEAT), a company specialising in the development and commercial exploitation of Intellectual Property portfolios. Previously, Philip held a range of management positions at AEAT where he started his career in 1990. As well as his experience in the orthopaedic and medical device market, Philip has led a range of multi-million pound international service businesses operating in the nuclear, oil & gas, chemical, transportation and defence markets.

Philip has a Master’s Degree and PhD in Chemistry from Cambridge University, a Master’s Degree in Business Administration from Warwick Business School, and became a Chartered Director in 2007.

Martin Pickford

Senior Vice President, Global Business Development

As Senior Vice President of Global Business Development, Martin is responsible for Accentus Medical’s commercial operation, as well as overseeing the company’s sales and marketing team.

Martin set up the operation which became Accentus Medical in 2000 and has played a pivotal role in the development and expansion of Accentus Medical’s business. He has also led the development of a new innovative anti-microbial surface modification process, within Accentus Medical, called Agluna®.

Martin brings a wealth of experience, spanning over 30 years, in the orthopaedic and medical device implant sector, having previously worked as Director for International Operations at Corin Medical, the UK’s largest orthopaedic device manufacturer. Formerly Martin was Vice President Europe for Zimmer Inc, one of the world’s leading orthopaedic companies. Prior to that he was the UK Sales and Marketing Manager for Edwards Laboratories, a leader in implantable cardiac devices.

Martin has a Bachelor’s Degree in Chemistry from Exeter University and a PhD in Chemistry from Portsmouth Polytechnic. Martin is a published scientist and experienced presenter on issues related to orthopaedic devices and clinical outcomes.

He is an Associate of the Royal Institute of Chemistry, a member of the British Orthopaedic Research Society and Orthopaedic Advisor to the UK National Joint Registry.

www.njrcentre.org.uk

James Shawcross

Vice President, Quality and Research & Development

As Vice President of Quality and R&D, James has direct responsibility for the development and oversight of the company’s quality management systems, as well as for delivery of research and development activities associated with emerging technologies such as Agluna®. He also coordinates the management of intellectual property portfolios within the company.

James joined Accentus (formerly AEA Technology) in 1996, where he was rapidly promoted from Research Scientist to Project Manager, Technology Manager and then Technology& Licence Manager. In this latter role he was responsible for managing and licensing a portfolio of patented technologies in a range of diverse markets including automotive, oil& gas, fluidic devices, electrochemistry and environmental technology.

James has a Bachelor’s Degree and PhD in Chemistry from Manchester University.

Andrew Turner

Chief Scientific Officer

As Chief Scientific Officer, Andrew is a key driver in the development of wear-resistant orthopaedic coatings and is a co-inventor of Accentus Medical’s new innovative anti-microbial surface modification process, Agluna®.

Formerly Andrew held a series of senior research and management positions at the UK Atomic Energy Authority, AEA Technology and Accentus. In these roles he increased the breadth and depth of his expertise through fundamental and process research and development, technical innovation, process and product engineering, as well as technology transfer that mainly focused on surface and process chemistry, and electrochemistry.

Andrew is a highly respected scientist and has published widely, including 16 peer reviewed scientific papers and 50 published conference presentations. He has also contributed to 15 books and 60 patent applications.

Andrew holds a DPhil, Electrochemistry and MA, Chemistry from the University of Oxford.

Thomas Salomon

Export Sales Manager

Thomas is Sales Manager for the Export territories, with a special focus on French and Swiss Markets. He is based in Lyon, France, which allows him to be easily accessible to Accentus Medical’s customers in and near this territory.

Over the past 10 years Thomas has worked for several companies in the medical device field; his experience includes orthopaedic and dental implant manufacture and orthopaedic plasma spraying technologies. He also has extensive knowledge of regulatory and quality system requirements for medical devices and is a fully accredited auditor for ISO 13485.

Thomas holds a Masters Degree in Bioengineering from the University of Lyon.

Adrian Godwin

Production Manager

Adrian joined Accentus Medical at the beginning of 2008 and became Production Manager in 2009. Adrian is directly responsibility for all production activities within Accentus Medical.

He has over 10 years experience within the manufacturing of medical devices, having previously worked in various roles for Penlon Ltd, one of the largest manufacturers of anaesthetic products in the UK. During this time, Adrian worked his way up to become Workshop Manager of the Manufacturing division which was certified to ISO 9001-2000 and ISO 13485-2003.

David Lewis

Laboratory Manager

David is responsible for managing the laboratory facilities within Accentus Medical and in this role he has overall responsibility for conducting the research and development programme with a special focus on the Agluna® anti-microbial technology. David has 15 years of experience in medical/pharmaceutical research.

He also oversees the regulatory testing of orthopaedic implants to International and ISO standards, performed for many of Accentus Medical’s global orthopaedic manufacturing customers.

Contact Philip

T: +44 (0) 1235 434328
E: philip.agg@accentus-medical.com

Contact Martin

T: +44 (0) 1235 434322
E: martin.pickford@accentus-medical.com

Contact James

T: +44 (0) 1235 828270
E: james.shawcross@accentus-medical.com

Contact Andrew

T: +44 (0) 1235 434330
E: andrew.turner@accentus-medical.com

Contact Thomas

T: +44 (0) 1235 434320
E: thomas.salomon@accentus-medical.com

Contact Adrian

T: +44 (0) 1235 434323
E: adrian.godwin@accentus-medical.com

Contact David

T: +44 (0) 1235 434325
E: david.lewis@accentus-medical.com

Contact Us

T: +44 (0)1235 434 320
F: +44 (0)1235 434 329
E: enquiries@accentus-medical.com